BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16244541)

  • 1. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.
    Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU
    Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma.
    Huang B; Deng S; Loo SY; Datta A; Yap YL; Yan B; Ooi CH; Dinh TD; Zhuo J; Tochhawng L; Gopinadhan S; Jegadeesan T; Tan P; Salto-Tellez M; Yong WP; Soong R; Yeoh KG; Goh YC; Lobie PE; Yang H; Kumar AP; Maciver SK; So JB; Yap CT
    Oncotarget; 2016 May; 7(18):25391-407. PubMed ID: 27058427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
    Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
    J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer.
    Tannapfel A; Wittekind C; Tahara E
    Z Gastroenterol; 1994 Feb; 32(2):91-3. PubMed ID: 8165832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
    Ahn SY; Kim J; Kim MA; Choi J; Kim WH
    Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.
    Noguchi E; Saito N; Kobayashi M; Kameoka S
    Mol Med Rep; 2015 May; 11(5):3423-31. PubMed ID: 25592281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
    Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
    World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
    Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
    Murakami N; Koufuji K; Shirouzu K
    Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.
    Lee JC; Koh SA; Lee KH; Kim JR
    Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.
    Li S; Zhang H; Wang X; Qu Y; Duan J; Liu R; Deng T; Ning T; Zhang L; Bai M; Zhou L; Wang X; Ge S; Ying G; Ba Y
    Tumour Biol; 2016 Nov; 37(11):15175-15183. PubMed ID: 27683052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
    Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
    J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.